Development and validation of animal model for study of metastatic bone tumor

Sunwook Park, Okhee Jeon, Chi Hyun Kim, Han Sung Kim, Keyoung Jin Chun, Dohyung Lim

Research output: Contribution to journalArticle

Abstract

Bone is one of the most favored sites of tumor metastasis. However, the existent animal models developed to understand mechanism of occurrence and progress of metastatic bone tumor generally showed difficulties of reproducibility and performance of longitudinal study, and inaccuracy of validation. The aim of this study was, therefore, to newly develop and accurately validate an animal model for study of metastatic bone tumor with overcome of the limitations shown in the existent animal models. Eighteen female Sprague-Dawley rats (12 weeks old, 250+7 g) were randomly allocated in Sham and Tumor groups. W256 breast cancer cell was inoculated in the right femur of the rat for Tumor group, while 0.9% NaCl was injected for Sham group. Urine was collected by metabolic cages for DPD (deoxypyridinoline) test in order to evaluate bone resorption at 0, 4, 8, 12 weeks after surgery. At the same time, the right hind limbs of all rats were scanned by in-vivo micro-computered tomography (CT) to identify tumor-mediated bone destruction driven from metastatic bone tumor. Finally, positron emission tomography was examined to directly identify existence of tumor cells inoculated in the bone. DPD test showed that bone resorption markedly increased in the bone of Tumor group compared to that of Sham group (p<0.05). In-vivo micro-computed tomography showed that there were significant bone losses and X-ray attenuation values in the bone of Tumor group compared to that of Sham group after surgery. In addition, tumor cells were directly identified in the bone of Tumor group by positron emission tomography, not in the bone of Sham group. The results indicated that the developed animal model might be confidential and reasonable to performances of studies related to metastatic bone tumor, with easy reproducibility, accuracy of validation, and suitability to performance of longitudinal study. To our knowledge, this study may prove valuable as the first development of the animal model overcoming the limitations shown in the existent animal models. The animal model developed in the present study may be useful for further metastatic bone tumor studies as mentioned.

Original languageEnglish
Pages (from-to)16-23
Number of pages8
JournalTissue Engineering and Regenerative Medicine
Volume7
Issue number1
Publication statusPublished - 2010 Jan 1

Fingerprint

Tumors
Bone
Animals
Animal Models
Bone and Bones
Neoplasms
Rats
Positron emission tomography
Bone Resorption
Cells
Positron-Emission Tomography
Longitudinal Studies
Surgery
Tomography
Femur
Sprague Dawley Rats
Extremities
X-Rays
Urine
Breast Neoplasms

All Science Journal Classification (ASJC) codes

  • Medicine (miscellaneous)
  • Biomedical Engineering

Cite this

Park, Sunwook ; Jeon, Okhee ; Kim, Chi Hyun ; Kim, Han Sung ; Chun, Keyoung Jin ; Lim, Dohyung. / Development and validation of animal model for study of metastatic bone tumor. In: Tissue Engineering and Regenerative Medicine. 2010 ; Vol. 7, No. 1. pp. 16-23.
@article{aa01fe380b8a4301b5e2a967170a101a,
title = "Development and validation of animal model for study of metastatic bone tumor",
abstract = "Bone is one of the most favored sites of tumor metastasis. However, the existent animal models developed to understand mechanism of occurrence and progress of metastatic bone tumor generally showed difficulties of reproducibility and performance of longitudinal study, and inaccuracy of validation. The aim of this study was, therefore, to newly develop and accurately validate an animal model for study of metastatic bone tumor with overcome of the limitations shown in the existent animal models. Eighteen female Sprague-Dawley rats (12 weeks old, 250+7 g) were randomly allocated in Sham and Tumor groups. W256 breast cancer cell was inoculated in the right femur of the rat for Tumor group, while 0.9{\%} NaCl was injected for Sham group. Urine was collected by metabolic cages for DPD (deoxypyridinoline) test in order to evaluate bone resorption at 0, 4, 8, 12 weeks after surgery. At the same time, the right hind limbs of all rats were scanned by in-vivo micro-computered tomography (CT) to identify tumor-mediated bone destruction driven from metastatic bone tumor. Finally, positron emission tomography was examined to directly identify existence of tumor cells inoculated in the bone. DPD test showed that bone resorption markedly increased in the bone of Tumor group compared to that of Sham group (p<0.05). In-vivo micro-computed tomography showed that there were significant bone losses and X-ray attenuation values in the bone of Tumor group compared to that of Sham group after surgery. In addition, tumor cells were directly identified in the bone of Tumor group by positron emission tomography, not in the bone of Sham group. The results indicated that the developed animal model might be confidential and reasonable to performances of studies related to metastatic bone tumor, with easy reproducibility, accuracy of validation, and suitability to performance of longitudinal study. To our knowledge, this study may prove valuable as the first development of the animal model overcoming the limitations shown in the existent animal models. The animal model developed in the present study may be useful for further metastatic bone tumor studies as mentioned.",
author = "Sunwook Park and Okhee Jeon and Kim, {Chi Hyun} and Kim, {Han Sung} and Chun, {Keyoung Jin} and Dohyung Lim",
year = "2010",
month = "1",
day = "1",
language = "English",
volume = "7",
pages = "16--23",
journal = "Tissue Engineering and Regenerative Medicine",
issn = "1738-2696",
publisher = "Springer Science + Business Media",
number = "1",

}

Development and validation of animal model for study of metastatic bone tumor. / Park, Sunwook; Jeon, Okhee; Kim, Chi Hyun; Kim, Han Sung; Chun, Keyoung Jin; Lim, Dohyung.

In: Tissue Engineering and Regenerative Medicine, Vol. 7, No. 1, 01.01.2010, p. 16-23.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Development and validation of animal model for study of metastatic bone tumor

AU - Park, Sunwook

AU - Jeon, Okhee

AU - Kim, Chi Hyun

AU - Kim, Han Sung

AU - Chun, Keyoung Jin

AU - Lim, Dohyung

PY - 2010/1/1

Y1 - 2010/1/1

N2 - Bone is one of the most favored sites of tumor metastasis. However, the existent animal models developed to understand mechanism of occurrence and progress of metastatic bone tumor generally showed difficulties of reproducibility and performance of longitudinal study, and inaccuracy of validation. The aim of this study was, therefore, to newly develop and accurately validate an animal model for study of metastatic bone tumor with overcome of the limitations shown in the existent animal models. Eighteen female Sprague-Dawley rats (12 weeks old, 250+7 g) were randomly allocated in Sham and Tumor groups. W256 breast cancer cell was inoculated in the right femur of the rat for Tumor group, while 0.9% NaCl was injected for Sham group. Urine was collected by metabolic cages for DPD (deoxypyridinoline) test in order to evaluate bone resorption at 0, 4, 8, 12 weeks after surgery. At the same time, the right hind limbs of all rats were scanned by in-vivo micro-computered tomography (CT) to identify tumor-mediated bone destruction driven from metastatic bone tumor. Finally, positron emission tomography was examined to directly identify existence of tumor cells inoculated in the bone. DPD test showed that bone resorption markedly increased in the bone of Tumor group compared to that of Sham group (p<0.05). In-vivo micro-computed tomography showed that there were significant bone losses and X-ray attenuation values in the bone of Tumor group compared to that of Sham group after surgery. In addition, tumor cells were directly identified in the bone of Tumor group by positron emission tomography, not in the bone of Sham group. The results indicated that the developed animal model might be confidential and reasonable to performances of studies related to metastatic bone tumor, with easy reproducibility, accuracy of validation, and suitability to performance of longitudinal study. To our knowledge, this study may prove valuable as the first development of the animal model overcoming the limitations shown in the existent animal models. The animal model developed in the present study may be useful for further metastatic bone tumor studies as mentioned.

AB - Bone is one of the most favored sites of tumor metastasis. However, the existent animal models developed to understand mechanism of occurrence and progress of metastatic bone tumor generally showed difficulties of reproducibility and performance of longitudinal study, and inaccuracy of validation. The aim of this study was, therefore, to newly develop and accurately validate an animal model for study of metastatic bone tumor with overcome of the limitations shown in the existent animal models. Eighteen female Sprague-Dawley rats (12 weeks old, 250+7 g) were randomly allocated in Sham and Tumor groups. W256 breast cancer cell was inoculated in the right femur of the rat for Tumor group, while 0.9% NaCl was injected for Sham group. Urine was collected by metabolic cages for DPD (deoxypyridinoline) test in order to evaluate bone resorption at 0, 4, 8, 12 weeks after surgery. At the same time, the right hind limbs of all rats were scanned by in-vivo micro-computered tomography (CT) to identify tumor-mediated bone destruction driven from metastatic bone tumor. Finally, positron emission tomography was examined to directly identify existence of tumor cells inoculated in the bone. DPD test showed that bone resorption markedly increased in the bone of Tumor group compared to that of Sham group (p<0.05). In-vivo micro-computed tomography showed that there were significant bone losses and X-ray attenuation values in the bone of Tumor group compared to that of Sham group after surgery. In addition, tumor cells were directly identified in the bone of Tumor group by positron emission tomography, not in the bone of Sham group. The results indicated that the developed animal model might be confidential and reasonable to performances of studies related to metastatic bone tumor, with easy reproducibility, accuracy of validation, and suitability to performance of longitudinal study. To our knowledge, this study may prove valuable as the first development of the animal model overcoming the limitations shown in the existent animal models. The animal model developed in the present study may be useful for further metastatic bone tumor studies as mentioned.

UR - http://www.scopus.com/inward/record.url?scp=84884555755&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84884555755&partnerID=8YFLogxK

M3 - Article

VL - 7

SP - 16

EP - 23

JO - Tissue Engineering and Regenerative Medicine

JF - Tissue Engineering and Regenerative Medicine

SN - 1738-2696

IS - 1

ER -